Literature DB >> 21872981

[Propensity score methods for creating covariate balance in observational studies].

Cassandra W Pattanayak1, Donald B Rubin, Elizabeth R Zell.   

Abstract

Randomization of treatment assignment in experiments generates treatment groups with approximately balanced baseline covariates. However, in observational studies, where treatment assignment is not random, patients in the active treatment and control groups often differ on crucial covariates that are related to outcomes. These covariate imbalances can lead to biased treatment effect estimates. The propensity score is the probability that a patient with particular baseline characteristics is assigned to active treatment rather than control. Though propensity scores are unknown in observational studies, by matching or subclassifying patients on estimated propensity scores, we can design observational studies that parallel randomized experiments, with approximate balance on observed covariates. Observational study designs based on estimated propensity scores can generate approximately unbiased treatment effect estimates. Critically, propensity score designs should be created without access to outcomes, mirroring the separation of study design and outcome analysis in randomized experiments. This paper describes the potential outcomes framework for causal inference and best practices for designing observational studies with propensity scores. We discuss the use of propensity scores in two studies assessing the effectiveness and risks of antifibrinolytic drugs during cardiac surgery. Published by Elsevier Espana.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21872981     DOI: 10.1016/j.recesp.2011.06.008

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  23 in total

1.  Surgery of the Primary Tumor Offers Survival Benefits of Breast Cancer with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis.

Authors:  Qi-Tong Chen; Li-Yun Zeng; Deng-Jie Ouyang; Piao Zhao; Qiong-Yan Zou; Lei Pei; Na Luo; Wen-Jun Yi
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

Review 2.  Propensity Score: an Alternative Method of Analyzing Treatment Effects.

Authors:  Oliver Kuss; Maria Blettner; Jochen Börgermann
Journal:  Dtsch Arztebl Int       Date:  2016-09-05       Impact factor: 5.594

3.  Prognostic value of increased carbohydrate antigen in patients with heart failure.

Authors:  Ana B Méndez; Jordi Ordoñez-Llanos; Andreu Ferrero; Mariana Noguero; Teresa Mir; Josefina Mora; Antoni Bayes-Genis; Sònia Mirabet; Juan Cinca; Eulàlia Roig
Journal:  World J Cardiol       Date:  2014-04-26

4.  Role of adjuvant chemotherapy in patients with localized, undifferentiated pleomorphic sarcoma of soft tissue: a population-based cohort study.

Authors:  Hiroshi Kobayashi; Liuzhe Zhang; Toshihide Hirai; Yusuke Tsuda; Masachika Ikegami; Sakae Tanaka
Journal:  Int J Clin Oncol       Date:  2022-01-22       Impact factor: 3.402

5.  Partial sick leave associated with disability pension: propensity score approach in a register-based cohort study.

Authors:  Johanna Kausto; Svetlana Solovieva; Lauri J Virta; Eira Viikari-Juntura
Journal:  BMJ Open       Date:  2012-11-08       Impact factor: 2.692

6.  Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method.

Authors:  Kotaro Fukubayashi; Motohiko Tanaka; Kazuhiro Izumi; Takehisa Watanabe; Satomi Fujie; Takeshi Kawasaki; Yoko Yoshimaru; Masakuni Tateyama; Hiroko Setoyama; Hideaki Naoe; Ken Kikuchi; Yutaka Sasaki
Journal:  Cancer Med       Date:  2015-06-04       Impact factor: 4.452

7.  Effectiveness of new legislation on partial sickness benefit on work participation: a quasi-experiment in Finland.

Authors:  Johanna Kausto; Eira Viikari-Juntura; Lauri J Virta; Raija Gould; Aki Koskinen; Svetlana Solovieva
Journal:  BMJ Open       Date:  2014-12-24       Impact factor: 2.692

8.  Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers.

Authors:  Tetsuro Tsujimoto; Takehiro Sugiyama; Martin F Shapiro; Mitsuhiko Noda; Hiroshi Kajio
Journal:  Hypertension       Date:  2017-05-30       Impact factor: 10.190

9.  Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.

Authors:  Bao-Jiang Liu; Song Gao; Xu Zhu; Jian-Hai Guo; Fu-Xin Kou; Shao-Xing Liu; Xin Zhang; Xiao-Dong Wang; Guang Cao; Hui Chen; Peng Liu; Lin-Zhong Zhu; Hai-Feng Xu; Ren-Jie Yang
Journal:  Biomed Res Int       Date:  2021-07-14       Impact factor: 3.411

10.  Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation.

Authors:  Takashi Tagami; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Front Med (Lausanne)       Date:  2015-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.